SIRT3 在破骨细胞中的线粒体蛋白去乙酰化作用会随着雌性小鼠的衰老而促进骨吸收。

IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Kimberly K. Richardson , Gareeballah Osman Adam , Wen Ling , Aaron Warren , Adriana Marques-Carvalho , Jeff D. Thostenson , Kimberly Krager , Nukhet Aykin-Burns , Stephanie D. Byrum , Maria Almeida , Ha-Neui Kim
{"title":"SIRT3 在破骨细胞中的线粒体蛋白去乙酰化作用会随着雌性小鼠的衰老而促进骨吸收。","authors":"Kimberly K. Richardson ,&nbsp;Gareeballah Osman Adam ,&nbsp;Wen Ling ,&nbsp;Aaron Warren ,&nbsp;Adriana Marques-Carvalho ,&nbsp;Jeff D. Thostenson ,&nbsp;Kimberly Krager ,&nbsp;Nukhet Aykin-Burns ,&nbsp;Stephanie D. Byrum ,&nbsp;Maria Almeida ,&nbsp;Ha-Neui Kim","doi":"10.1016/j.molmet.2024.102012","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The mitochondrial deacetylase sirtuin-3 (SIRT3) is necessary for the increased bone resorption and enhanced function of mitochondria in osteoclasts that occur with advancing age; how SIRT3 drives bone resorption remains elusive.</p></div><div><h3>Methods</h3><p>To determine the role of SIRT3 in osteoclast mitochondria, we used mice with conditional loss of <em>Sirt3</em> in osteoclast lineage and mice with germline deletion of either <em>Sirt3</em> or its known target <em>Pink</em>1.</p></div><div><h3>Results</h3><p>SIRT3 stimulates mitochondrial quality in osteoclasts in a PINK1-independent manner, promoting mitochondrial activity and osteoclast maturation and function, thereby contributing to bone loss in female but not male mice. Quantitative analyses of global proteomes and acetylomes revealed that deletion of <em>Sirt3</em> dramatically increased acetylation of osteoclast mitochondrial proteins, particularly ATPase inhibitory factor 1 (ATPIF1), an essential protein for mitophagy. Inhibition of mitophagy via mdivi-1 recapitulated the effect of deletion of <em>Sirt3</em> or <em>Atpif1</em> in osteoclast formation and mitochondrial function.</p></div><div><h3>Conclusions</h3><p>Decreasing mitophagic flux in osteoclasts may be a promising pharmacotherapeutic approach to treat osteoporosis in older adults.</p></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"88 ","pages":"Article 102012"},"PeriodicalIF":7.0000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212877824001431/pdfft?md5=a9155d0d1cfd89d98d7d2140e9f088ca&pid=1-s2.0-S2212877824001431-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice\",\"authors\":\"Kimberly K. Richardson ,&nbsp;Gareeballah Osman Adam ,&nbsp;Wen Ling ,&nbsp;Aaron Warren ,&nbsp;Adriana Marques-Carvalho ,&nbsp;Jeff D. Thostenson ,&nbsp;Kimberly Krager ,&nbsp;Nukhet Aykin-Burns ,&nbsp;Stephanie D. Byrum ,&nbsp;Maria Almeida ,&nbsp;Ha-Neui Kim\",\"doi\":\"10.1016/j.molmet.2024.102012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>The mitochondrial deacetylase sirtuin-3 (SIRT3) is necessary for the increased bone resorption and enhanced function of mitochondria in osteoclasts that occur with advancing age; how SIRT3 drives bone resorption remains elusive.</p></div><div><h3>Methods</h3><p>To determine the role of SIRT3 in osteoclast mitochondria, we used mice with conditional loss of <em>Sirt3</em> in osteoclast lineage and mice with germline deletion of either <em>Sirt3</em> or its known target <em>Pink</em>1.</p></div><div><h3>Results</h3><p>SIRT3 stimulates mitochondrial quality in osteoclasts in a PINK1-independent manner, promoting mitochondrial activity and osteoclast maturation and function, thereby contributing to bone loss in female but not male mice. Quantitative analyses of global proteomes and acetylomes revealed that deletion of <em>Sirt3</em> dramatically increased acetylation of osteoclast mitochondrial proteins, particularly ATPase inhibitory factor 1 (ATPIF1), an essential protein for mitophagy. Inhibition of mitophagy via mdivi-1 recapitulated the effect of deletion of <em>Sirt3</em> or <em>Atpif1</em> in osteoclast formation and mitochondrial function.</p></div><div><h3>Conclusions</h3><p>Decreasing mitophagic flux in osteoclasts may be a promising pharmacotherapeutic approach to treat osteoporosis in older adults.</p></div>\",\"PeriodicalId\":18765,\"journal\":{\"name\":\"Molecular Metabolism\",\"volume\":\"88 \",\"pages\":\"Article 102012\"},\"PeriodicalIF\":7.0000,\"publicationDate\":\"2024-08-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2212877824001431/pdfft?md5=a9155d0d1cfd89d98d7d2140e9f088ca&pid=1-s2.0-S2212877824001431-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212877824001431\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212877824001431","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

研究目的线粒体去乙酰化酶sirtuin-3(SIRT3)是随着年龄增长而出现的骨吸收增加和破骨细胞线粒体功能增强的必要条件;SIRT3如何驱动骨吸收仍是一个谜:为了确定SIRT3在破骨细胞线粒体中的作用,我们使用了破骨细胞系中Sirt3条件性缺失的小鼠和Sirt3或其已知靶标Pink1种系缺失的小鼠:结果:SIRT3以一种与PINK1无关的方式刺激破骨细胞中线粒体的质量,促进线粒体活性以及破骨细胞的成熟和功能,从而导致雌性小鼠的骨质流失,而非雄性小鼠的骨质流失。全局蛋白质组和乙酰基组的定量分析显示,Sirt3的缺失显著增加了破骨细胞线粒体蛋白的乙酰化,尤其是ATPase抑制因子1(ATPIF1),它是有丝分裂的必需蛋白。通过mdivi-1抑制有丝分裂再现了缺失Sirt3或ATPIF1对破骨细胞形成和线粒体功能的影响:结论:降低破骨细胞的有丝分裂通量可能是治疗老年人骨质疏松症的一种很有前景的药物治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice

Objectives

The mitochondrial deacetylase sirtuin-3 (SIRT3) is necessary for the increased bone resorption and enhanced function of mitochondria in osteoclasts that occur with advancing age; how SIRT3 drives bone resorption remains elusive.

Methods

To determine the role of SIRT3 in osteoclast mitochondria, we used mice with conditional loss of Sirt3 in osteoclast lineage and mice with germline deletion of either Sirt3 or its known target Pink1.

Results

SIRT3 stimulates mitochondrial quality in osteoclasts in a PINK1-independent manner, promoting mitochondrial activity and osteoclast maturation and function, thereby contributing to bone loss in female but not male mice. Quantitative analyses of global proteomes and acetylomes revealed that deletion of Sirt3 dramatically increased acetylation of osteoclast mitochondrial proteins, particularly ATPase inhibitory factor 1 (ATPIF1), an essential protein for mitophagy. Inhibition of mitophagy via mdivi-1 recapitulated the effect of deletion of Sirt3 or Atpif1 in osteoclast formation and mitochondrial function.

Conclusions

Decreasing mitophagic flux in osteoclasts may be a promising pharmacotherapeutic approach to treat osteoporosis in older adults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Metabolism
Molecular Metabolism ENDOCRINOLOGY & METABOLISM-
CiteScore
14.50
自引率
2.50%
发文量
219
审稿时长
43 days
期刊介绍: Molecular Metabolism is a leading journal dedicated to sharing groundbreaking discoveries in the field of energy homeostasis and the underlying factors of metabolic disorders. These disorders include obesity, diabetes, cardiovascular disease, and cancer. Our journal focuses on publishing research driven by hypotheses and conducted to the highest standards, aiming to provide a mechanistic understanding of energy homeostasis-related behavior, physiology, and dysfunction. We promote interdisciplinary science, covering a broad range of approaches from molecules to humans throughout the lifespan. Our goal is to contribute to transformative research in metabolism, which has the potential to revolutionize the field. By enabling progress in the prognosis, prevention, and ultimately the cure of metabolic disorders and their long-term complications, our journal seeks to better the future of health and well-being.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信